study published April 15 in JAMA Network Open found that more and more US patients who smoke are asking their doctors about e-cigarettes—and that, as a result, more and more physicians are recommending them.
This is the case even though a majority of doctors remain misinformed about the basics of tobacco harm reduction…
Continue ReadingOne of the newest and most promising is hexahydrocannabinol, usually shortened to HHC. 3chi HHC,
HHC disposable vape,
HHC gummies and bulk HHC distillate slowly are making their rounds. Hexahydrocannabinol for sale…
The CBD industry remains largely unregulated, even though it is booming. For the general public, it is impossible to tell the difference between good companies and bad companies, and therefore, good CBD products, and bad CBD products. This is where third party testing comes in. What is third party testing for CBD?
Continue ReadingThe industry continues demonstrating to the world that, despite legal status, cannabis is not immune to the wave of automation we’ve been seeing in recent years; and as such, the industry has even developed its own version of technology known as “cannatech”. The integration of cannatech in the age-old world of cannabis is resulting in cutting-edge technologies that impact nearly every aspect of the industry, including cultivation.
Continue ReadingMany Silicon Valley workers have come out and said that they frequently microdose shrooms and LSD to help them think outside of the box, as well as making them more productive. But what’s the reasoning behind this? Is there any science to back up these claims of increased creativity and productivity? And who are the silicon valley tech workers using this new method of psychedelia?
Continue ReadingCredit: Media Relations
Researchers found that synthetic cannabidiol (CBD) augments the anti-viral response of cells to three key proteins produced by the SARS-CoV-2 genome – which was, until now, an unknown effect…
Credit: Audrey Carleton
Cannabidiol—the non-psychoactive cannabis compound better known as CBD—is a potent blocker of SARS-CoV-2 replication in human cells, new research shows. Not only that, but a survey of real-world patients taking prescribed CBD found a “significant” negative relationship between CBD consumption and COVID-19 infection.
Credit: Patricia Miller
Cannabigerolic acid (CBGA) and cannabidiolic acid (CBDA), two compounds commonly found in cannabis, have potential to fight the virus that causes COVID-19. During a chemical screening, researchers from Oregon State University bound spike proteins found on the virus and blocked a step the pathogen uses to infect people.
Credit: Terry Hacienda
A new study from Augusta University, focused on glioblastoma, one of the deadliest and fastest growing forms of brain tumors, reveals that cannabidiol (CBD) is a beneficial form of treatment. The prognosis for glioblastoma is a 15-month survival rate following diagnosis, based on data from the Glioblastoma Foundation.
Credit: Andrew DeWeese. Researchers at Oregon State University have found that cannabigerolic acid (CBGA) and cannabidiolic acid (CBDA) “bind to the SARS-CoV-2 spike protein, blocking a critical step in the process the virus uses to infect people.”
Continue Reading
